Oral and Topical Sirolimus for Vascular Anomalies: A Multicentre Study and Review.

Sandbank, Shira; Molho-Pessach, Vered; Farkas, Adam; Barzilai, Aviv; Greenberger, Shoshana

Sandbank, Shira; Molho-Pessach, Vered; Farkas, Adam; Barzilai, Aviv; Greenberger, Shoshana.

Affiliation

Sandbank S; Department of Dermatology, Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Acta Derm Venereol ; 99(11): 990-996, 2019 Oct 01.

Article in En | MEDLINE | ID: mdl-31304557

Subject(s)

Antineoplastic Agents/administration & dosage; Protein Kinase Inhibitors/administration & dosage; Sirolimus/administration & dosage; TOR Serine-Threonine Kinases/antagonists & inhibitors; Vascular Malformations/drug therapy; Vascular Neoplasms/drug therapy; Administration, Cutaneous; Administration, Oral; Adolescent; Age Factors; Antineoplastic Agents/adverse effects; Child; Child, Preschool; Female; Humans; Infant; Israel; Male; Protein Kinase Inhibitors/adverse effects; Remission Induction; Retrospective Studies; Signal Transduction; Sirolimus/adverse effects; TOR Serine-Threonine Kinases/metabolism; Time Factors; Treatment Outcome; Vascular Malformations/diagnosis; Vascular Malformations/enzymology; Vascular Neoplasms/diagnosis; Vascular Neoplasms/enzymology; Young Adult

Key words

rapamycin; vascular anomalies; vascular malformation; sirolimus

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Vascular Neoplasms / Sirolimus / Protein Kinase Inhibitors / Vascular Malformations / TOR Serine-Threonine Kinases / Antineoplastic Agents Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Country/Region as subject: Asia Language: En Year: 2019 Type: Article

Fulltext

XML

PubMed Links

Search on Google